Abiopharma

🔍 Heitel Stephen G. (Director)

Company: HERITAGE COMMERCE CORP (HTBK)

Report Date: 2026-04-17

Detailed Transactions and Holdings:

• Sold 216,078 shares of Common Stock, No Par Value (Direct)
  Date: 2026-04-17 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On April 17, 2026 (the "Effective Time"), upon consummation of the transactions contemplated by the Agreement and Plan of Reorganization and Merger (the "Merger Agreement"), dated as of December 17, 2025, by and between Heritage Commerce Corp (the "Company"), a California corporation and CVB Financial Corp. ("CVBF"), a California corporation, and subject to the terms and conditions set forth in the Merger Agreement, each share of the Company's common stock outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive 0.65 shares (the "Exchange Ratio") of CVBF's common stock, without interest thereon (the "Merger Consideration").
• F2: At the Effective Time, each outstanding restricted stock award granted under any Company stock plan accelerated in full, and such restricted stock awards were converted into, and became exchanged for, the Merger Consideration.